An observational study in Osteoporosis and Telemedicine, sponsored by Antalya Training and Research Hospital. Completed at 2 sites in Turkey. Open to female participants aged 50 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-25.
Sponsored by Antalya Training and Research Hospital · Observational
This study aims to explore the needs and expectations of women with postmenopausal osteoporosis regarding telemedicine services. Osteoporosis is a common condition among postmenopausal women that increases the risk of fractures and significantly affects quality of life. Many patients do not receive enough information about their disease and treatments during routine clinic visits, which may affect their ability to manage osteoporosis effectively. Participants will be divided into two age groups: those younger than 65 and those aged 65 or older. These subgroups will be compared in terms of their willingness to use telemedicine, their perceived need for such services, their expectations, preferred service topics, and anticipated barriers.
Telemedicine-including video consultations, remote monitoring, and online health education-can offer support to patients, especially for those facing difficulties in accessing healthcare, such as elderly individuals, those living in rural areas, or people with mobility issues.
In this research, women aged 50 to 85 who have been diagnosed with postmenopausal osteoporosis will be asked to complete a survey. The survey includes questions about their needs for telemedicine services, including which types of services (such as medication counseling, exercise programs, dietary advice, psychological support) would be most helpful for them.
The study will also examine if age, education level, past fractures, or family history of osteoporosis influence patients' preferences for telemedicine. By identifying these needs, this research aims to improve access to healthcare and develop personalized telemedicine services for women with osteoporosis in Turkey.
This is a non-interventional, observational, and anonymous survey-based study that will take approximately 10-15 minutes to complete. No medications, treatments, or physical tests will be applied.
This observational, cross-sectional study investigates the actual needs, preferences, and expectations of postmenopausal women with osteoporosis regarding the use of telemedicine services. Osteoporosis is a chronic, progressive condition characterized by decreased bone density and increased fracture risk, which can significantly impair mobility, and overall quality of life. Access to ongoing medical support is crucial for these patients, yet many-particularly older individuals-encounter substantial barriers such as physical limitations, transportation difficulties, limited caregiver availability, or lack of local specialist services.
Telemedicine has gained prominence as a solution to these challenges, offering remote access to healthcare services through technologies like video consultations, telephone check-ins, and online education tools. While telemedicine has been widely implemented during the COVID-19 pandemic, there remains a lack of data on how women with postmenopausal osteoporosis view these services, what features they find most useful, and what obstacles they anticipate.
The primary objective of this study is to evaluate which types of telemedicine services are most needed and preferred by this patient population-for example, support related to medication use, exercise programs, and dietary advice. The study also aims to determine whether specific sociodemographic and clinical variables-such as age, education level, marital status-are associated with participants' willingness to use telemedicine and their actual need for it.
To examine age-related differences, participants will be divided into two subgroups: those under 65 years of age and those aged 65 or older. These subgroups will be compared across multiple domains, including their interest in using telemedicine, actual necessity for such services (calculated according to parameters living alone, not driving/owning a car, having a chronic disease other than osteoporosis), expectations for care delivery, preferred content areas, and potential barriers (such as lack of internet access or digital literacy).
Data will be collected using a structured, self-administered questionnaire developed through expert consultation and adapted from validated tools in previous telehealth research. The questionnaire includes closed-ended questions and will be distributed during routine outpatient visits at two regional hospitals. Participants will be informed about the purpose of the study and assured of full anonymity and confidentiality. Completing the questionnaire is voluntary and is estimated to take approximately 10-15 minutes.
By identifying telemedicine-related needs specific to postmenopausal women with osteoporosis, this study seeks to support the creation of age-appropriate, patient-centered telehealth models. These findings may also inform healthcare providers and policymakers on how to design and implement accessible, effective, and equitable digital healthcare interventions to improve long-term disease management and patient outcomes in this growing patient population.
1,640 studies on the registry are indexed under Osteoporosis; 212 are open to participants now.
This study's enrollment of 197 is above the median of 174 across 446 observational studies indexed under Osteoporosis.
Browse Osteoporosis studies →Antalya Training and Research Hospital is the lead sponsor of 102 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population will include postmenopausal women aged 50 to 85 years with a confirmed diagnosis of osteoporosis. Participants will be recruited from patients attending the Physical Medicine and Rehabilitation Department of Antalya City Hospital and the Gynecology Department of Antalya Anadolu Hospital. To reduce selection bias, a systematic sampling method was employed, whereby every third consecutive woman with osteoporosis who presented to the outpatient clinics during the data collection period was invited to participate in the study.
Female patients aged 50 to 85 years. Diagnosed with osteoporosis (based on clinical evaluation and prior diagnosis). Able to understand and complete the study questionnaire (adequate cognitive function).
Willing and able to provide informed consent and voluntarily participate in the study.
Exclusion Criteria:
Presence of severe medical conditions that may interfere with participation, including:
Severe cardiac diseases (e.g., advanced heart failure). Severe pulmonary diseases (e.g., advanced chronic obstructive pulmonary disease).
Advanced-stage cancer or other life-limiting illnesses. Cognitive impairment preventing understanding or completion of the questionnaire.
Participation in another clinical or interventional study at the same time. Recent significant trauma (physical or psychological) that may interfere with study participation.
Individuals who cannot understand the study goals and risks, or who refuse informed consent.
Participants will be divided into two age groups. The younger age group will include participants below 65.
Other: Structured Questionnaire on Telemedicine Needs
Participants will be divided into two age groups. The older age group will include participants equal to or above 65.
Other: Structured Questionnaire on Telemedicine Needs
Participants will complete a structured questionnaire designed to assess their telemedicine needs, expectations, and current knowledge. The questionnaire includes items on demographics, osteoporosis management, and telemedicine service expectations. No clinical or pharmacological intervention will be applied.
Also known as: There is no other intervention.
Intention to Use Telemedicine Services
Participants were directly asked in the questionnaire about their willingness to use telemedicine services. Response options included "Yes," "Not sure," and "No."
Time frame: Day 1
Telemedicine Needs Index
The Telemedicine Need Index was calculated based on three demographic factors: living alone (scored 1), not driving or owning a car (scored 1), and having a chronic disease other than osteoporosis (scored 1). These scores were summed, yielding a total score ranging from 0 to 3. A score of 2 or higher indicated a high need for telemedicine services. Higher scores reflected a greater need for telemedicine.
Time frame: Day 1
Differences of telemedicine willingness and need between age groups
Intention to use telemedicine services (answers as yes, not and not sure) and the need for telemedicine (Telemedicine Need Index (scored 0 to 3)) were compared between younger (below 65) older (equal to or above 65) participant.
Time frame: Day 1
Patient-reported barriers to telemedicine use
Identification of barriers via questionnaire (technological, privacy, etc.).
Time frame: Day 1
Preferred topics for telemedicine services
Patient preferences for telemedicine content (e.g., medication, diet).
Time frame: Day 1
Perceived impact of telemedicine on Quality of Life
Likert-scale rating of expected impact of telemedicine on quality of life. Participants rated the perceived impact of telemedicine on their quality of life using a 5-point Likert scale: 1 = Not effective at all, 2 = Slightly effective, 3 = Moderately effective, 4 = Very effective, 5 = Extremely effective. Higher scores indicate a stronger belief that telemedicine services will improve quality of life.
Time frame: Day 1
Plan to share: Yes — IPD related to demographics (such as age and education level, marital status), and responses to the telemedicine needs questionnaire will be available upon reasonable request from the corresponding author. No personally identifiable information will be shared.
This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Antalya Training and Research Hospital